ERYTECH provides business update and financial results for the first half of 2015 Post author:admERY Post published:September 28, 2015 Post category:Newsroom ERYTECH provides a business update and reports its financial results for the six-month period ending June 30, 2015. You Might Also Like ERYTECH Announces Publication of Positive Results from Eryaspase Phase 2 Trial in Hypersensitive ALL in the British Journal of Haematology April 6, 2022 ERYTECH Provides Business Update and Reports Financial Results for Full Year 2016 March 2, 2017 ERYTECH Announces Launch of Investigator-Initiated Phase 2 Study of eryaspase (GRASPA®) for ALL April 4, 2017
ERYTECH Announces Publication of Positive Results from Eryaspase Phase 2 Trial in Hypersensitive ALL in the British Journal of Haematology April 6, 2022
ERYTECH Announces Launch of Investigator-Initiated Phase 2 Study of eryaspase (GRASPA®) for ALL April 4, 2017
